Navigation Links
Stem Cell Banking Evokes Mixed Response

Cord blood banking initiative by Sir Richard Branson has received a mixed and varied response in Britain. While this was welcomed by the doctors and scientific community,// others opined that it may not be as beneficial as it sounds.

The human blood extracted from placenta and umbilical cord is called cord blood. This can be collected before the placenta is delivered or after the newborn baby is separated from the umbilical cord. This blood is an excellent source of hematopoietic stem cells which can be further stored and used for transplantation needs.

Currently there are private and public cord blood banks. While the public banks are generally used for everyone, private ones are meant for the families of the donors.

According to Professor Robin Lovell-Badge of Medical Research Council National Institute for Medical Research, the use of these stem cells can only be limited to treat a set of disorders of the blood. But the embryonic stem cells may have more remedial measures in treating degenerative diseases.

Many of them seem to concur with the guarded approach of the Royal College of Obstetricians and Gynaecologists (RCOG) which felt that children from low-risk families cannot be treated with private cord blood.

Dr Jacky Boivin from Cardiff University feels that the family should be adequately informed about the storage of cold blood and they should not under any circumstances be forced to take emotional decisions.

But the midwives have a different perspective to the entire issue. They feel that their primary objective of delivering a baby should not be diverted as safety of the mother and the newborn is of utmost importance than drawing blood from the cord or placenta.
JYT
'"/>




Page: 1

Related medicine news :

1. A Novel System For Clinical Banking Of Umbilical Cord Blood
2. A Worm Turns: Banking on Blood From a Little Lugworm
3. Doctor Dissuades Mothers from Umbilical Cord Banking
4. Banking (T)issues : cloning issue surfaces
5. Umbilical Cord Blood Banking of Negligible Value: Experts
6. Choking Game, Rage Among US Teens, Evokes Deep Concern
7. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
8. New Medicare Plan - Mixed Reaction among Pharmacists.
9. Mixed Orientation Marriages Calls for Deeper Understanding
10. Mixed response Evoked Among The Tribal Elders For The Call On Smoking Ban
11. Mixed Wards Cause Trauma in Female Patients in Britain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stem Cell Banking Evokes Mixed Response

Other Medicine News:Health News:Video: Grin Big With an Award-Winning Smile 2Health News:Video: Grin Big With an Award-Winning Smile 3Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 2Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 3Health News:Pharmos Restructures Operations in Israel 2Health News:Pharmos Restructures Operations in Israel 3Health News:Ranbaxy Receives Tentative Approval For Valsartan Tablets 2Health News:TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 3Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 4Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 5
Breaking Medicine Technology:Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 1Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 2Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 3Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 1Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 2Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8